Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. In addition, we also examine blood and urine biomarkers (proteins).

Inclusion Criteria:

• Undergoing heart surgery
• Willing to provide consent

Exclusion Criteria:

• Enrolled in a concurrent drug or device trial that precludes concurrent enrollment